Mike Evers, Author at ORTHOWORLD

Paragon 28 Sets Out to Modernize Foot and Ankle Surgery

The company grew almost 33% in 2021 and expects its focus on medical education and enabling technology will spur further growth.

Mar 11, 2022

The company grew in the low-teens for 2021 but the ongoing effects of the pandemic caused Anika to adjust its growth timeline.

Mar 10, 2022

The company grew +25% in 2022 and took its U.S. business to the next level with the acquisition of Nextremity Solutions.

Mar 09, 2022

The company grew nearly 65% in 2021 and believes its focus on bunion surgery will reveal further opportunities for clinical distinction.

Mar 08, 2022

The company grew nearly 38% in 2021 and expects another strong year in 2022 on the strength of a growing surgeon base and new products.

Mar 07, 2022

The company grew 45% in 2021 on the strength of non-recurring royalty payments, but product revenue remains well below pre-pandemic levels.

Mar 04, 2022

The company grew nearly 70% in 2021, making it one of the premier growth stories in medtech. ATEC is bullish on its future prospects.

Mar 03, 2022

The company grew over 20% in 2021 and expects similar growth in 2022 due to its expanded portfolio and exclusive payor coverage.

Mar 02, 2022

The company grew almost 19% in 2021 while playing plans to expand production capacity and expand MACI's indication to the ankle.

Mar 01, 2022

The company grew 1% over its 2019 total and sees this year as a bridge to consistent mid-single-digit growth in the future.

Feb 28, 2022